Pfizer – Quality Improvement Grant – Appropriate Immunization among Patients with Immune-Mediated Inflammatory Diseases (IMIDs) – Request for Proposals
Academic Unit: Inquire within your unit
Memorial Deadline: Tuesday 6th, July 2021
External Deadline: Monday 12th, July 2021
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the practice gaps as outlined in the specific RFP.
For all independent quality improvement grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct or monitoring of the quality improvement program.
The aim of this RFP is to support the care of patients with Immune Mediated Inflammatory Diseases (IMIDs), including patients under traditional immuno suppressive therapies and advanced therapies, aiming to reduce the impact of vaccine-preventable diseases by improving or facilitating appropriate vaccination practices or/and addressing gaps in vaccination status in those patients.
Additional information can be found here.
**As the sponsor deadline falls on Memorial’s MID-JULY holiday of July 12th (Holiday schedule for all administrative, technical, and technical support staff) these application will be submitted to the sponsor on Friday, July 9th.